Did You Miss: Transforming Toxicology Prediction via PanOmics
We recently announced the latest edition of Evotec’s Drug Discovery Update (DDup). This edition is dedicated to our next generation transcriptomics toxicology platform, a truly translational project across different groups at Evotec.
The development of this platform has been a combined effort of toxicology experts, bioinformaticians and transcriptomics specialists leading to one of our latest offerings, a unique end-to-end in vitro toxicology transcriptomics service that can be customised according to customer’s needs.
From March 12-26 2021, Cyprotex and parent company, Evotec, will be exhibiting at the Annual Society of Toxicology Meeting (SOT). At this virtual event you can find us at booth number 1941 (Cyprotex) and 2040 (Evotec).
Our panel of experts will be on hand to discuss your project and keep you up-to-date on our latest research. You can request a virtual meeting with them by contacting us:
Webinar Series: Navigating the Drug Discovery to Development Continuum
Early stage key decisions in drug discovery strongly influence overall development cost, time and the probability of delivering a successful new medicine.
In this webinar series, scientific experts will present on Evotec's differentiated approach to drug discovery and development by considering it as a continuum rather than discrete hand-over between traditionally separate departments. This integrated approach has enabled invention and selection of the highest quality molecules leading to improved success rates during preclinical development candidate nomination and clinical development.